Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Dicerna Pharmaceuticals: Institutional Buying Heats Up [Seeking Alpha]

Dicerna Pharmaceuticals, Inc. (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com
Company Research Source: Seeking Alpha
Dicerna Pharmaceuticals: Institutional Buying Heats UpSummaryDicerna Pharmaceuticals is up +17.72% YTD with at least 20% more upside potential in the short term.Institutional investors substantially increasing positions in DRNA over decreasing investments at 36:1.Collaboration and licensing efforts are generating increasing income and advances in pipeline success.Current price breakout above November, 2017 highs could be significant technical breakout to price target of 12 and higher. Show less Read more
Impact Snapshot
Event Time:
DRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DRNA alerts
Opt-in for
DRNA alerts

from News Quantified
Opt-in for
DRNA alerts

from News Quantified